Non-Malaysian citizens are subject to 6% SST, to be verified and paid at the counter before screening.
Thyroid Tumor Markers (MX, TX, CLT, CEX, THY)
Overview
This comprehensive panel includes MX, TX, CLT, CEX, and THY tumor markers associated with thyroid tumor and thyroid cancer risk assessment. It helps evaluate thyroid cell activity, detect potential malignant changes, and monitor post-treatment or recurrence status. Results should always be interpreted alongside imaging studies and a doctor’s clinical evaluation.
Why Take the Thyroid Tumor Marker Test?
- Risk Evaluation: Helps identify individuals with potential thyroid tumor or thyroid cancer risks for early management.
- Treatment Monitoring: Used to observe response to therapy and detect possible recurrence after surgery or radioiodine treatment.
- Comprehensive Health Management: Supports long-term thyroid health tracking as part of a cancer marker profile.
Test Components and Clinical Significance
- MX / TX / THY: Indicators reflecting thyroid tissue differentiation, commonly used for follow-up in differentiated thyroid cancers such as papillary or follicular types.
- CLT (Calcitonin): A sensitive marker related to Medullary Thyroid Carcinoma (MTC), useful in diagnosis and monitoring after treatment.
- CEX (CEA-type marker): Often tested together with Calcitonin to assess MTC treatment response and recurrence.
⚠️ Note: Laboratory methods and reference ranges may vary. Always refer to your test report and consult your doctor for accurate interpretation.
Who Should Consider This Test?
- Individuals with thyroid nodules, neck swelling, hoarseness, or difficulty swallowing
- People with a family history of thyroid cancer or prior head/neck radiation exposure
- Patients who have been treated for thyroid cancer and require follow-up evaluation
- Individuals undergoing general or targeted tumor marker screening upon physician’s advice
Test Method
A small amount of venous blood is collected and analyzed for serum tumor marker levels. Results are reported with numerical values and reference ranges. For accuracy, doctors recommend comparing new results with previous reports to observe trends over time.
Precautions
- Inflammation, medications, or liver/kidney function changes may affect marker levels.
- Different laboratories may use varied detection methods; follow the reference range on your report.
- Continuous monitoring is more meaningful than single-time results.
- Always follow your doctor’s advice for follow-up or repeat testing schedules.
Frequently Asked Questions (FAQ)
Q1: Does a high tumor marker mean I have thyroid cancer?
A: Not necessarily. Tumor markers help assess risk but cannot confirm cancer alone. Diagnosis requires imaging and pathology.
Q2: Can this test rule out thyroid cancer completely?
A: No. A normal result doesn’t exclude disease. It must be interpreted in combination with imaging and clinical evaluation.
Q3: How often should I retest?
A: It depends on your clinical condition and doctor’s advice. Post-surgery or post-treatment patients usually follow a periodic monitoring plan.
If you have any health-related questions, feel free to contact us via WhatsApp at
CONTACT US. We will arrange a one-on-one consultation with a dedicated specialist to provide you with detailed explanations and recommendations.
Pre-Screening Preparation